2017

Dec 08

Life Sciences Ontario Announces Recipients of 2018 LSO Awards

By stan@produktiv.agency Media

TORONTO– LSO today announced the recipients of its 2018 LSO Awards, recognizing outstanding individuals and companies contributing to the success…

Sep 25

Love0

Fusion Pharmaceuticals Completes Oversubscribed Series A Financing Totaling $46 Million USD to Develop Targeted Alpha Therapeutics

By stan@produktiv.agency Media

HAMILTON, ONTARIO, September 25, 2017 – Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer, today announced it…

Feb 23

Love0

Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments

By stan@produktiv.agency Media

HAMILTON ONTARIO, February 23, 2017 – Fusion Pharmaceuticals, a newly formed biopharmaceutical company developing targeted alpha-particle radiotherapeutics for treating cancer,…

Life Sciences Ontario Announces Recipients of 2018 LSO Awards

Fusion Pharmaceuticals Completes Oversubscribed Series A Financing Totaling $46 Million USD to Develop Targeted Alpha Therapeutics

Fusion Pharmaceuticals Launches with a $25M USD Series A Financing to Develop Targeted Radiotherapeutics as Cancer Treatments

Archives